A detailed history of Goldman Sachs Group Inc transactions in Penumbra Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 286,762 shares of PEN stock, worth $67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
286,762
Previous 485,005 40.87%
Holding current value
$67 Million
Previous $87.3 Million 36.21%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.64 - $210.12 $32.4 Million - $41.7 Million
-198,243 Reduced 40.87%
286,762 $55.7 Million
Q2 2024

Aug 13, 2024

BUY
$172.27 - $223.95 $68.7 Million - $89.3 Million
398,620 Added 461.45%
485,005 $87.3 Million
Q1 2024

May 15, 2024

SELL
$220.09 - $273.15 $8.02 Million - $9.95 Million
-36,430 Reduced 29.66%
86,385 $19.3 Million
Q4 2023

Feb 13, 2024

SELL
$181.44 - $260.22 $13.9 Million - $20 Million
-76,786 Reduced 38.47%
122,815 $30.9 Million
Q3 2023

May 14, 2024

BUY
$240.69 - $338.77 $18.5 Million - $26 Million
76,786 Added 62.52%
199,601 $48.3 Million
Q3 2023

Nov 14, 2023

SELL
$240.69 - $338.77 $22.9 Million - $32.3 Million
-95,273 Reduced 32.31%
199,601 $48.3 Million
Q2 2023

May 14, 2024

BUY
$271.54 - $344.06 $57.2 Million - $72.4 Million
210,532 Added 249.62%
294,874 $101 Million
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $57.2 Million - $72.4 Million
210,532 Added 249.62%
294,874 $101 Million
Q1 2023

May 14, 2024

SELL
$220.43 - $278.69 $13.8 Million - $17.5 Million
-62,635 Reduced 42.62%
84,342 $23.5 Million
Q1 2023

May 11, 2023

SELL
$220.43 - $278.69 $13.8 Million - $17.5 Million
-62,635 Reduced 42.62%
84,342 $23.5 Million
Q4 2022

May 14, 2024

BUY
$151.88 - $228.5 $1 Million - $1.51 Million
6,599 Added 4.7%
146,977 $32.7 Million
Q4 2022

Feb 13, 2023

BUY
$151.88 - $228.5 $1 Million - $1.51 Million
6,599 Added 4.7%
146,977 $32.7 Million
Q3 2022

May 14, 2024

SELL
$120.36 - $205.88 $11.9 Million - $20.4 Million
-98,923 Reduced 41.34%
140,378 $26.6 Million
Q3 2022

Nov 10, 2022

SELL
$120.36 - $205.88 $11.9 Million - $20.4 Million
-98,923 Reduced 41.34%
140,378 $26.6 Million
Q2 2022

May 14, 2024

BUY
$116.09 - $227.33 $13.5 Million - $26.5 Million
116,486 Added 94.85%
239,301 $29.8 Million
Q2 2022

Aug 15, 2022

BUY
$116.09 - $227.33 $2.33 Million - $4.56 Million
20,049 Added 9.14%
239,301 $29.8 Million
Q1 2022

May 16, 2022

BUY
$187.51 - $283.98 $21 Million - $31.8 Million
111,824 Added 104.09%
219,252 $48.7 Million
Q4 2021

Feb 14, 2022

SELL
$238.08 - $288.0 $38.9 Million - $47 Million
-163,198 Reduced 60.3%
107,428 $30.9 Million
Q3 2021

Nov 10, 2021

BUY
$250.72 - $291.24 $67.9 Million - $78.8 Million
270,626 New
270,626 $72.1 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $8.85B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.